Fatal misonidazole-induced encephalopathy: an RTOG case report.
A case of fatal encephalopathy following administration of misonidazole (MISO) is reported. Anorexia and dehydration preceded signs of encephalopathy after a cumulative dose of 18 g (11 g/m2) of MISO in five weekly doses. Serum MISO levels four hours after weekly administrations were markedly elevated. Postmortem examination revealed focal cortical neuronal necrosis and hemorrhage with focal demyelination. The possible relationship of dehydration or altered drug metabolism to the development of MISO central nervous system toxicity is noted.
D001927:Brain Diseases / Q000139:chemically induced* / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008875:Middle Aged; D008920:Misonidazole / Q000009:adverse effects*; D009593:Nitroimidazoles / Q000009:adverse effects*; D010157:Palatal Neoplasms / Q000188:drug therapy; D014062:Tongue Neoplasms / Q000188:drug therapy
D009593:Nitroimidazoles; D008920:Misonidazole